plerixafor has been researched along with Alveolar Bone Atrophy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bak, EJ; Kim, AR; Yoo, YJ | 1 |
| Hajishengallis, G; McIntosh, ML | 1 |
2 other study(ies) available for plerixafor and Alveolar Bone Atrophy
| Article | Year |
|---|---|
Distribution of neutrophil and monocyte/macrophage populations induced by the CXCR4 inhibitor AMD3100 in blood and periodontal tissue early after periodontitis induction.
Topics: Alveolar Bone Loss; Animals; Benzylamines; Cyclams; Lipopolysaccharides; Macrophages; Mice; Monocytes; Neutrophils; Periodontitis | 2022 |
Inhibition of Porphyromonas gingivalis-induced periodontal bone loss by CXCR4 antagonist treatment.
Topics: Alveolar Bone Loss; Animals; Anti-Bacterial Agents; Bacterial Load; Bacteroidaceae Infections; Benzylamines; Cyclams; Disease Models, Animal; Disease Progression; Heterocyclic Compounds; Infusion Pumps, Implantable; Mice; Mice, Inbred BALB C; Periodontitis; Porphyromonas gingivalis; Real-Time Polymerase Chain Reaction; Receptors, CXCR4 | 2012 |